Original Article

Safety of Inactivated Vaccines in Patients Receiving Immune Checkpoint Inhibitors

Austin Kurkowski, PharmD, BCOP; Grace A. Martin, PharmD, BCOP; Shelbie Ralph, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; Dennis Grauer, PhD, MS; Elizabeth Wulff-Burchfield, MD

Myeloablative and Reduced-Intensity Preparative Regimens for Allogeneic Transplant in the Outpatient versus Inpatient Setting in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

Gretchen Pardo, PharmD; Beth Eddy, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; Dennis Grauer, PhD, MS; Joseph P. McGuirk, DO

Comparing Cyclophosphamide-Based versus Etoposide-Based Chemomobilization for Autologous Hematopoietic-Cell Transplant in Patients with Lymphoma

Taylor Dennison, PharmD; Zachary Pedretti, PharmD; Jing Zhu, PharmD; Kurtis Stocker, PharmD; Ryan Shaw, PharmD; Tatjana Grgic, PharmD; Maurice Alexander, PharmD; Marcie Riches, MD, MS; Hillary Heiling, BS; Jonathan Ptachcinski, PharmD

Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis

Katherine P. Morgan, PharmD, BCOP, CPP; Yujiao Sun, PharmD; Allison Deal; Jared Weiss, MD; Amber Cipriani, PharmD, BCOP

Jessica M. Tran, PharmD, BCPS; Ni-Chi Wu, PharmD, BCOP, BCPS; Rajkumar J. Sevak, PhD, RPh; Pankaj Gupta, MD, FACP

Pharmacy Resident–Led Medication Reconciliation and Patient Education Service in Adults with Leukemia Receiving Anticancer Oral Agents: A Pilot Study

Lily Y. Jia, PharmD, BCOP; Jessie Signorelli, PharmD, BCOP; Samantha O. Luk, PharmD, BCOP; E. Bridget Kim, PharmD, BCPS, BCOP; Gayle C. Blouin, PharmD, BCOP

Corrections

Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center

Andrew Kowalski, PharmD, BCOP; Sara Mohamed Jaszczur, PharmD, BCOP; Michelle Nadeau-Nguyen, PharmD, BCPS; Man Yee Merl, PharmD, BCOP

Comparison of Direct Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Obese or Overweight Patients: A Retrospective Analysis

Jennifer C. Cook, PharmD; Tracy E. Wiczer, BCOP, PharmD; Anthony T. Gerlach, PharmD, FCCM, FCCP; Caitlin Linger, PharmD; Meghan E. Ritchey, PharmD Candidate; Bridgette M. Zickefoose, PharmD; Tzu-Fei Wang, MD; Kristin I. Brower, BCPS, PharmD

Optimizing Daratumumab Infusion: Assessing the Safety and Feasibility of Omitting Preinfusion Medications and Decreasing Infusion Time

Justine Preedit, PharmD; Anya Yudchyts, PharmD, BCOP

Page 1 of 9
Results 1 - 10 of 85